Gainers Bolt Biotherapeutics (NASDAQ:BOLT) shares moved upwards by 58.8% to $6.65 during Friday&#39

Gainers Disc Medicine (NASDAQ:IRON) stock moved upwards by 50.4% to $85.51 during Monday's pre-

Gainers Marker Therapeutics (NASDAQ:MRKR) stock increased by 21.2% to $1.11 during Friday's reg

Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares increased by 27.9% to $2.79 during Friday's p

Alcoa shares rose after Q3 earnings beat estimates; Rubico and others surged, while Nuburu, Jaguar H

Gainers Alaunos Therapeutics (NASDAQ:TCRT) stock rose 34.9% to $2.94 during Thursday's after-ma

Gainers Liquidia (NASDAQ:LQDA) shares moved upwards by 41.0% to $37.8 during Wednesday's pre-ma

Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares rose 20.5% to $3.65 during Tuesday's after-ma

Alaunos Therapeutics, Inc. (NASDAQ:TCRT) stock is surging on Tuesday with a massive session volume o

Alaunos Therapeutics acquired Velaris and raised $350 million to advance clinical therapies for pulm

Gainers Alaunos Therapeutics (NASDAQ:TCRT) stock moved upwards by 203.8% to $3.19 during Tuesday&#3

Acquisition of Velaris and concurrent oversubscribed $350 million private placement positions the Co

Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares rose 93.3% to $2.03 during Tuesday's pre-mark

Leadership team brings proven company-building and drug development experience to Paragon following

Gainers XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 7.8% to $1.52 during Friday's

Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-mark

Gainers IM Cannabis (NASDAQ:IMCC) stock increased by 246.0% to $6.02 during Friday's regular se

The offering is expected to close on or about September 21, 2026, subject to the satisfaction of cus

Alaunos Therapeutics announces pricing of a public offering of common stock and pre-funded warrants

Gainers IM Cannabis (NASDAQ:IMCC) stock rose 108.5% to $3.63 during Friday's pre-market session

TCRT: 69% | Alaunos Therapeutics On Thursday Filed Patent Application "Identification Of Neoanti

https://ppubs.uspto.gov/api/pdf/downloadPdf/US-20260273054-A1?source=US-PGPUB&requestToken=eyJzd

Shares of Alaunos Therapeutics Inc (NASDAQ:TCRT) rose sharply in pre-market trading following a Secu

Alaunos rose 21.8% after adopting amended bylaws; Cheetah Net led gainers, while Xenon dropped 27.6%

Alaunos Therapeutics shares surged 29% in after-hours trading Thursday after the company adopted new

Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares moved upwards by 30.0% to $2.08 during Thursday&#

Gainers Basel Medical Group (NASDAQ:BMGL) stock moved upwards by 14.1% to $4.68 during Wednesday&#3

Gainers DataMEDS AI (NASDAQ:MEDS) shares rose 124.1% to $3.63 during Wednesday's pre-market ses

Gainers VolitionRX (AMEX:VNRX) shares increased by 102.2% to $0.69 during Thursday's pre-market

This statistical finding supports a lower liver-weight signal after adjustment for body fat percenta

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday&

ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, includin

ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, includin

Alaunos Therapeutics, Inc. (NASDAQ:TCRT) today announced updated preclinical data from non-GLP diet-

FORT LAUDERDALE, Fla., May 18, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT) to

Seasoned Biopharmaceutical Attorney with Deep IP, Clinical-Stage, and Nasdaq Public Company Experien

Alaunos Therapeutics Inc. (NASDAQ: TCRT) shares are down on Monday after the company announced precl

The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body compositio

Alaunos' ALN1003 shows dose dependent weight loss, better body composition, reduced liver weight, an

Alaunos Therapeutics, Inc. (NASDAQ: TCRT - Get Free Report) saw a significant decline in short inter

Alaunos Therapeutics, Inc. (NASDAQ: TCRT - Get Free Report) was up 3.1% during mid-day trading on We

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names h